Substance / Medication

Rimexolone

Overview

Active Ingredient
rimexolone
RxNorm CUI
55681

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
0
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
[0.1% dexamathasone and 1% rimexolone. A comparative study in the postoperative treatment after cataract extraction].
Vico-Ruiz E, Benítez-Del-Castillo-Sánchez J M, Cuiña-Sardiña R et al. · Arch Soc Esp Oftalmol · 2009
PMID: 19568990Observational
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery.
Kavuncu Sevim, Horoz Hasan, Ardagil Aylin et al. · Int Ophthalmol · 2008
PMID: 17762913Observational
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
Hirneiss Christoph, Neubauer Aljoscha S, Kampik Anselm et al. · Graefes Arch Clin Exp Ophthalmol · 2005
PMID: 15756571Observational
Rimexolone-induced intraocular pressure elevation.
Cazabon S, Morrell A J · Eye (Lond) · 2001
PMID: 11702986Case Report
Outcome and risk of ocular complications of managing children with chronic anterior uveitis with topical rimexolone 1.
Chen Yi-Hsing, Gepstein Raz, Sharief Lazha et al. · Int Ophthalmol · 2020
PMID: 32318939Other
Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells.
Spies Cornelia M, Gaber Timo, Hahne Martin et al. · Immunol Lett · 2010
PMID: 20363256Other
Effect of topical dexamethasone versus rimexolone on middle ear inflammation in experimental otitis media with effusion.
Florea Andrew, Zwart Jon E, Lee Choong-Won et al. · Acta Otolaryngol · 2006
PMID: 16864486Preclinical
Efficacy and safety of 1% rimexolone versus 1% prednisolone acetate in the treatment of anterior uveitis--a randomized triple masked study.
Biswas Jyotirmay, Ganeshbabu T M, Raghavendran S Ramesh et al. · Int Ophthalmol · 2004
PMID: 15847313Trial
Ocular-hypertensive and anti-inflammatory response to rimexolone therapy in children.
Fan Dorothy S P, Yu Christopher B O, Chiu Thomas Y H et al. · Arch Ophthalmol · 2003
PMID: 14662591Trial

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Rimexolone (substance)
SNOMED CT
387046003
UMLS CUI
C0140594
RxNorm CUI
55681

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.